Exponent, Inc. (NASDAQ:EXPO) VP Richard Reiss Sells 1,736 Shares

Exponent, Inc. (NASDAQ:EXPO) VP Richard Reiss sold 1,736 shares of the business’s stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total value of $149,174.48. Following the transaction, the vice president now owns 1,800 shares in the company, valued at $154,674. This represents a 49.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Exponent Stock Down 1.1 %

Shares of EXPO opened at $84.66 on Friday. Exponent, Inc. has a 12-month low of $77.21 and a 12-month high of $115.75. The firm has a market capitalization of $4.30 billion, a price-to-earnings ratio of 39.93 and a beta of 0.71. The stock’s 50-day moving average price is $89.78 and its 200 day moving average price is $98.96.

Exponent (NASDAQ:EXPO) last issued its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same quarter last year, the business earned $0.41 EPS. Equities research analysts expect that Exponent, Inc. will post 1.98 EPS for the current year.

Exponent Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Friday, March 7th will be paid a $0.30 dividend. This is a positive change from Exponent’s previous quarterly dividend of $0.28. This represents a $1.20 annualized dividend and a dividend yield of 1.42%. The ex-dividend date of this dividend is Friday, March 7th. Exponent’s dividend payout ratio is currently 56.60%.

Institutional Investors Weigh In On Exponent

Large investors have recently modified their holdings of the stock. Barclays PLC grew its stake in shares of Exponent by 219.0% in the 3rd quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock valued at $11,127,000 after purchasing an additional 66,263 shares during the period. Geneva Capital Management LLC grew its stake in shares of Exponent by 1.7% in the 3rd quarter. Geneva Capital Management LLC now owns 1,590,804 shares of the business services provider’s stock valued at $183,388,000 after purchasing an additional 27,339 shares during the period. JPMorgan Chase & Co. grew its stake in shares of Exponent by 63.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock valued at $72,701,000 after purchasing an additional 245,086 shares during the period. Argent Capital Management LLC grew its stake in shares of Exponent by 17.3% in the 4th quarter. Argent Capital Management LLC now owns 28,323 shares of the business services provider’s stock valued at $2,524,000 after purchasing an additional 4,173 shares during the period. Finally, Citigroup Inc. grew its stake in shares of Exponent by 174.7% in the 3rd quarter. Citigroup Inc. now owns 48,309 shares of the business services provider’s stock valued at $5,569,000 after purchasing an additional 30,723 shares during the period. 92.37% of the stock is currently owned by institutional investors.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.